Sprache: Englisch
Verlag: Berlin/ Heidelberg, Springer Berlin., 2001
ISBN 10: 3540678492 ISBN 13: 9783540678496
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
2001. 15 x 23 cm. XXX, 526 S. XXX, 526 p. 31 illus. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Handbook of Experimental Pharmacology). Sprache: Englisch.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 310,79
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 2001
ISBN 10: 3540678492 ISBN 13: 9783540678496
Anbieter: moluna, Greven, Deutschland
EUR 336,82
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. With contributions by numerous experts|This two-part volume is an update and objective state of the art of the current knowledge in the field, with particular emphasis on the development of novel therapeutic entities that may prove useful in several disease.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 454,16
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 442 pages. 9.25x6.25x0.75 inches. In Stock.
Sprache: Englisch
Verlag: Springer, Berlin, Springer, 2001
ISBN 10: 3540678492 ISBN 13: 9783540678496
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Physiological, pharmacological and molecular biological data generated over the past three decades have demonstrated the existence of two major families of extracellular receptors, the P1, a family of four G-protein coupled receptors and the P2, a family of at least 12 receptors responsive to purine (ATP, ADP) and pyrimidine (UTP) nucleotides through which adenosine and ATP can function as extracellular messengers. The present two-part volume represents an integrated compendium of invited chapters by leading researchers in the area focusing on advances in the understanding of purinergic and pyrimidinergic signaling systems, their role(s) in tissue function and pathophysiology and advances in developing potential new medications based on the modulation of P1 and P2 receptor signaling processes. The volumes will thus provide the reader with a topical, comprehensive and integrated overview of this important area.